Joshua N Sampson1, Simina M Boca2, Steven C Moore1, Ruth Heller3. 1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. 2. Department of Oncology and Department of Biostatistics, Bioinformatics & Biomathematics, Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC, USA. 3. Department of Statistics and Operations Research, Tel Aviv University, Tel Aviv, Israel.
Abstract
Motivation: The biological pathways linking exposures and disease risk are often poorly understood. To gain insight into these pathways, studies may try to identify biomarkers that mediate the exposure/disease relationship. Such studies often simultaneously test hundreds or thousands of biomarkers. Results: We consider a set of m biomarkers and a corresponding set of null hypotheses, where the jth null hypothesis states that biomarker j does not mediate the exposure/disease relationship. We propose a Multiple Comparison Procedure (MCP) that rejects a set of null hypotheses or, equivalently, identifies a set of mediators, while asymptotically controlling the Family-Wise Error Rate (FWER) or False Discovery Rate (FDR). We use simulations to show that, compared to currently available methods, our proposed method has higher statistical power to detect true mediators. We then apply our method to a breast cancer study and identify nine metabolites that may mediate the known relationship between an increased BMI and an increased risk of breast cancer. Availability and implementation: R package MultiMed on https://github.com/SiminaB/MultiMed. Supplementary information: Supplementary data are available at Bioinformatics online.
Motivation: The biological pathways linking exposures and disease risk are often poorly understood. To gain insight into these pathways, studies may try to identify biomarkers that mediate the exposure/disease relationship. Such studies often simultaneously test hundreds or thousands of biomarkers. Results: We consider a set of m biomarkers and a corresponding set of null hypotheses, where the jth null hypothesis states that biomarker j does not mediate the exposure/disease relationship. We propose a Multiple Comparison Procedure (MCP) that rejects a set of null hypotheses or, equivalently, identifies a set of mediators, while asymptotically controlling the Family-Wise Error Rate (FWER) or False Discovery Rate (FDR). We use simulations to show that, compared to currently available methods, our proposed method has higher statistical power to detect true mediators. We then apply our method to a breast cancer study and identify nine metabolites that may mediate the known relationship between an increased BMI and an increased risk of breast cancer. Availability and implementation: R package MultiMed on https://github.com/SiminaB/MultiMed. Supplementary information: Supplementary data are available at Bioinformatics online.
Authors: P A van den Brandt; D Spiegelman; S S Yaun; H O Adami; L Beeson; A R Folsom; G Fraser; R A Goldbohm; S Graham; L Kushi; J R Marshall; A B Miller; T Rohan; S A Smith-Warner; F E Speizer; W C Willett; A Wolk; D J Hunter Journal: Am J Epidemiol Date: 2000-09-15 Impact factor: 4.897
Authors: Quynh C Nguyen; Theresa L Osypuk; Nicole M Schmidt; M Maria Glymour; Eric J Tchetgen Tchetgen Journal: Am J Epidemiol Date: 2015-02-17 Impact factor: 4.897
Authors: Oliver Y Chén; Ciprian Crainiceanu; Elizabeth L Ogburn; Brian S Caffo; Tor D Wager; Martin A Lindquist Journal: Biostatistics Date: 2018-04-01 Impact factor: 5.899
Authors: Michaël G B Blum; Linda Valeri; Olivier François; Solène Cadiou; Valérie Siroux; Johanna Lepeule; Rémy Slama Journal: Environ Health Perspect Date: 2020-05-06 Impact factor: 9.031